| Financial Year |
March 31 2023 |
| Monetary Funds |
186,419,234.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
665,208,052.76 |
| Advances to Suppliers |
47,807,436.81 |
| Other Receivables |
48,658,192.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,267,544.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,390,386.70 |
| Other Current Assets |
243,148,254.02 |
| Total Current Assets |
1,223,899,102.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,913,342.63 |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,053,884.63 |
| Fixed Assetes |
6,976,447.93 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,198,649.76 |
| R&D expenses |
2,178,453.44 |
| Goodwill |
601,748,352.06 |
| Long-Term Deferred and Prepaid Expenses |
1,044,218.80 |
| Deferred Income Tax Assets |
6,184,437.07 |
| Other Non-Current Assets |
2,481,488.08 |
| Sub-Total of Non-Current Assets |
787,903,419.32 |
| Total Assets |
2,011,802,521.32 |
| Short-Term Loans |
550,349,987.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
52,330,056.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,317,788.47 |
| Taxes Payable |
4,800,723.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,407,822.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,292,276.56 |
| Other Current Liabilities |
9,138,499.96 |
| Sub-Total of Current Liabilities |
783,039,534.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,089,581.01 |
| Deferred Income Tax Liabilities |
6,601,976.64 |
| Other Non-Current Liabilities |
400,000.00 |
| Sub-Total of Non-Current Liabilities |
22,270,472.37 |
| Total Liabilities |
805,310,006.96 |
| Paid-In Capital(Or Share Stock) |
658,993,677.00 |
| Capital Surplus |
1,847,148,249.58 |
| Surplus Reserve |
30,962,021.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,298,390,042.17 |
| Minority Stockholder's Interest |
-20,967,374.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,227,459,888.96 |
| Owner's Equity（Stockholder's Equity） |
1,206,492,514.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,011,802,521.32 |
